Skip to content
value.today
Balaxi Pharmaceuticals Limited logo

Balaxi Pharmaceuticals Limited

BALAXI.NS
$22 Mmarket cap on Nov 19, 2026-59.1% since Jan 2024
1D
+18.0%
Compare
World rank
#23,993
Revenue
—
annual
Net income
—
Employees
—

Balaxi Pharmaceuticals Limited in brief

Balaxi Pharmaceuticals Limited is a listed company in the Biotechnology industry, based in India. Its market value was $22 M on 19 November 2026, which makes it the 23,993rd largest listed company in the world and the 2,221st largest in India on this site. Its shares trade under the symbol BALAXI.NS (NSE).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Balaxi Pharmaceuticals Limited timeline

1 events, 2015
  1. 2015
  2. 📈
    Listed on National Stock Exchange of India as BALAXI
    First day of listing in the exchange's official list.

Events of Balaxi Pharmaceuticals Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Balaxi Pharmaceuticals Limited share price · NSE (BALAXI.NS)

daily · 1,937 trading days since 2017
Last close 37.30 INR (Nov 19, 2026)1 month: +71.4%1 year: +3.7%5 years: -93.3%52-week range 15.20 – 40.98 INR
$0 M$281 M$562 M$843 M$1.1 B201820192020202120222023202420252026
DateOpenHighLowCloseChangeVolume
Nov 19, 202631.8037.9831.8037.30+17.9%3.3 M
Nov 18, 202630.0031.7627.8031.65+19.6%1.8 M
Nov 17, 202622.4026.4722.4026.47+20.0%248,665
Nov 16, 202623.6023.6021.8022.06-5.9%16,771
Nov 13, 202623.9923.9922.5023.44-1.7%14,070
Nov 12, 202623.0825.5522.7023.84+5.2%69,337
Nov 11, 202622.7023.4422.4022.67+0.0%24,904
Nov 9, 202622.6423.0021.8522.66+3.2%16,632
Nov 6, 202622.4022.4021.3021.96+0.3%12,945
Nov 5, 202620.9022.3520.7721.89+6.8%17,898
Nov 4, 202619.7521.0019.7520.50+1.2%7,784
Nov 3, 202619.7520.9219.3720.26+2.6%8,509
Nov 2, 202619.6019.9919.2119.75+3.1%6,108
Oct 30, 202619.9919.9918.7019.15-2.8%21,377
Oct 29, 202620.6020.6019.1619.71-3.0%31,016
Oct 28, 202620.2221.2019.8020.33+0.6%16,375
Oct 27, 202620.0020.4720.0020.21+2.6%12,072
Oct 26, 202621.1021.1019.5019.70-5.8%24,393
Oct 23, 202621.1821.1819.3520.91-0.4%40,139
Oct 22, 202621.1021.3019.1621.00-0.5%62,006
Oct 21, 202622.3522.3521.0021.10-3.0%23,032
Oct 19, 202622.0922.3421.6021.76-1.5%19,900
Oct 16, 202622.6022.6021.8022.09-0.2%13,444
Oct 15, 202622.4022.6221.8522.13-0.2%10,714
Oct 14, 202622.4022.4021.7022.18-0.0%8,605
Oct 13, 202622.5822.5821.5022.19-0.8%26,229
Oct 12, 202622.3322.9022.3022.36+0.1%16,602
Oct 9, 202622.4022.7922.0922.33+1.1%13,772
Oct 8, 202622.8123.4021.0522.09-1.3%61,447
Oct 7, 202622.9523.4922.2222.38—15,155

Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.

Balaxi Pharmaceuticals Limited share price statistics

computed nightly from the daily prices
NSE · BALAXI.NSClose 37.30 INR (Nov 19, 2026)
1 day
+17.9%
1 week
+56.5%
1 month
+71.4%
3 months
+56.8%
Year to date
+38.8%
1 year
+3.7%
3 years
-91.0%
5 years
-93.3%
10 years
—
52-week low 15.20-9.0% from the highhigh 40.98
Highest on record 1,080 INR (Oct 14, 2020)Volume 196,666 shares/dayValue traded 6.6 M INR/dayVolatility 95% (30d), 57% (1y)1,937 trading days on record

Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.

Market cap history

$0 M$19 M$38 M$57 M$76 M2023202420252026

World rank over time

▲ up 1,000 places since 2022
2022-01-07: #24993#24,99320222022-12-25: #23480#23,48020222023-07-30: #24096#24,09620232024-01-05: #24508#24,50820242026-03-08: #12605#12,60520262026-11-12: #24359#24,35920262026-11-13: #25152#25,15220262026-11-16: #25485#25,48520262026-11-17: #25015#25,01520262026-11-18: #24542#24,54220262026-11-19: #23993#23,9932026

Rank in India: #1,213 (Jan 2022) · #1,185 (Dec 2022) · #1,267 (Jul 2023) · #1,343 (Jan 2024) · #1,825 (Mar 2026) · #2,414 (Nov 2026) · #2,424 (Nov 2026) · #2,451 (Nov 2026) · #2,365 (Nov 2026) · #2,295 (Nov 2026) · #2,221 (Nov 2026)

How Balaxi Pharmaceuticals Limited compares in Biotechnology

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Balaxi Pharmaceuticals Limited🇮🇳$22 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Nov 19, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, value.today research, NSE India.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Balaxi Pharmaceuticals Limited? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Balaxi Pharmaceuticals Limited's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Balaxi Pharmaceuticals Limited? Suggest a correction